Trial NCT02588261

View at ClinicalTrials.gov 
Org. Study IDs: 8273-CL-0302
Secondary IDs: 2015-002894-39

Last trial update was posted on 2019-02-12

MeSH Interventions

Erlotinib Hydrochloride Gefitinib Naquotinib

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-small Cell Lung Cancer (NSCLC)

Stopping Reasons

Following recommendation by SOLAR Study IDMC, Astellas closed enrollment in ASP8273 studies

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID